TWO · Healthcare

GeneFerm Biotechnology Co Ltd (1796)

Drug Manufacturers - Specialty & Generic

GeneFerm Biotechnology Co Ltd (1796) is listed on TWO in the Healthcare sector. Industry: Drug Manufacturers - Specialty & Generic. As of 2026-05-23, reported P/E ratio is 18.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Download on the App Store Get it on Google Play

Key metrics for 1796

P/E ratio

18.00

GeneFerm Biotechnology Co Ltd (1796) — FAQ

What is 1796's P/E ratio?

The price-to-earnings (P/E) ratio for GeneFerm Biotechnology Co Ltd (1796) is 18.00 (data as of 2026-05-23).

Does GeneFerm Biotechnology Co Ltd pay a dividend?

Dividend yield is not available in the current snapshot for GeneFerm Biotechnology Co Ltd (1796). Check the MyAverix Finance app for the latest dividend data.

What sector is GeneFerm Biotechnology Co Ltd in?

GeneFerm Biotechnology Co Ltd (1796) is classified in the Healthcare sector (Drug Manufacturers - Specialty & Generic industry).

What exchange is 1796 listed on?

1796 is listed on TWO.

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Healthcare companies

Abbott Laboratories (ABT) AbbVie Inc. CDR (ABBV) Agilent Technologies Inc. (A1GI34) Aimed Bio (0009K0) Alnylam Pharmaceuticals, Inc. (A1LN34) Alvotech (ALVO) Amgen Inc (AMGN34) argenx SE (A1RG34)